CRO

China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report
Endpoints
Mon, 07/20/20 - 10:22 am
China
Hong Kong
Hangzhou Tigermed
CRO
biotech
IPOs
How Covid-19 is accelerating adoption of decentralized clinical trials
MedCity News
Tue, 06/9/20 - 11:33 pm
clinical trials
pandemic
COVID-19
decentralized clinical trials
CRO
Covance
Medable
Charles River Labs to buy HemaCare for $380M, expands in cell therapy market
Biopharma Dive
Thu, 12/19/19 - 06:13 pm
Charles River Laboratories
CRO
HemaCare
cell therapy
M&A
Eisai extends CRO partnership for malaria drug discovery
BioPharma Dive
Thu, 06/1/17 - 02:47 pm
Eisai
CRO
drug development
malaria
LabCorp bags Covance, diversifying into CRO biz with $6.1B buyout
Fierce Biotech
Mon, 11/3/14 - 09:31 am
Covance
LabCorp
M&A
CRO
diagnostics